Lyme Disease Treatment Market is estimated to witness high growth owing to rising demand for diagnostic tests

Lyme Disease Treatment Market 


Lyme disease is a bacterial infection caused by Borrelia burgdorferi that is transmitted to humans through the bite of infected blacklegged ticks. Early symptoms may include fever, headache, fatigue, and skin rash known as erythema migrans. If left untreated, later symptoms can involve joints, heart, and nervous system. Lyme disease has been recognized as an emerging public health concern worldwide and suitable precautions are required to avoid contracting this zoonotic infection. Lyme disease treatment involves use of oral or intravenous antibiotics such as doxycycline, amoxicillin or cefuroxime. Various diagnostic tests such as ELISA, Western Blot are used to confirm Lyme disease.


The global Lyme Disease Treatment Market is estimated to be valued at US$ 1.56 Bn in 2023 and is expected to exhibit a CAGR of 5.0% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:
With rising incidence rates of Lyme disease cases globally, the demand for effective diagnostic tests is expected to grow significantly over the forecast period. According to CDC, every year around 476,000 Americans are diagnosed and treated for Lyme disease. However, the cases are underreported with estimated actual number of diagnosed cases reaching around 300,000 each year. This vast patient pool presents lucrative opportunities for diagnostic kit manufacturers to strengthen their geographic presence and commercialize sensitive diagnostic tests to aid early detection and treatment of Lyme disease. Development of rapid point-of-care tests with high accuracy will witness high adoption and drive the growth of Lyme disease treatment market during the forecast period.

Porter's Analysis
Threat of new entrants: The threat of new entrants is moderate due to high research and development cost involved in developing new treatment drugs and vaccines for Lyme disease. Bargaining power of buyers: The bargaining power of buyers is high due to presence of many established pharmaceutical companies offering substitutable generic treatment drugs. Bargaining power of suppliers: The bargaining power of suppliers is low as raw material suppliers include common suppliers for pharmaceutical industry. Threat of new substitutes: The threat of new substitutes is high since other treatment methods like herbal medicines and supplements can be used as substitutes. Competitive rivalry: The competitive rivalry is high due to presence of many established global as well as local players offering generic drugs.

SWOT Analysis
Strength: Established global pharmaceutical companies have strong research expertise and financial resources to develop innovative treatment drugs. Weakness: High cost of R&D for developing new drugs and vaccines. Dependence on seasonal factors for cases reporting. Opportunity: Increasing incidence rate of Lyme disease globally presents growth opportunities. Scope for developing low cost generic drugs. Threats: Strong regulatory approvals process for new drugs increases time to market. Herbal alternatives and natural remedies may hamper sales.

Key Takeaways
Global Lyme Disease Treatment Market Demand is expected to witness high growth over the forecast period due to increasing incidence rate globally especially in North America and Europe. The United States dominated the global market and accounted for majority market share in 2023 led by large patient pool and favorable reimbursement scenario. Key regional growth opportunities include European market supported by improving diagnostics and increasing approval of novel drugs and vaccines.

Key players operating in the Lyme disease treatment market are Sanofi, Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals, Zydus Cadila, Lannett Company, Inc., Strides Pharma Science Limited, Cipla Ltd., Lupin Limited, Aurobindo Pharma Limited, Torrent Pharmaceuticals Ltd., Reddy's Laboratories Ltd. Sanofi and Pfizer are the leading players due to their innovative late stage pipeline molecules.

Comments

Post a Comment

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

Image
Security Robot Market The Security Robot Market is estimated to be valued at US$ 11.8 billion in 2022 and is expected to exhibit a CAGR of 12.87% over the forecast period of 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Security Robot Market encompasses advanced robotic technologies that are specifically designed and developed to enhance security and surveillance operations. These robots are equipped with features such as video surveillance, thermal imaging, facial recognition, and intrusion detection, among others. They are extensively used by security agencies and organizations across various sectors, including residential, commercial, industrial, and government, to enhance safety, reduce human intervention, and streamline security operations. Security robots offer real-time monitoring, remote control, and high accuracy, making them an ideal choice for surveillance in sensitive areas and remote locations. Market Dynamics:
Read more

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

Image
  Scottish Whisky Market The Scottish Whisky Market is a captivating landscape that has been evolving and transforming over the years. It is a world of tradition, craftsmanship, and heritage, where every drop of whisky tells a story. The history of Scottish whisky traces back centuries, with the earliest records dating back to the 15th century. Whisky production initially started in monasteries, where monks distilled spirits for medicinal purposes. Over time, whisky production moved from monastic settings to farms and then to commercial distilleries. This transition marked the beginning of an industry that would become synonymous with Scotland. Scottish Whisky Market Was Valued At US$ 4.97 Bn In 2018, And It Is Expected To Reach US$ 7.89 Bn By The End Of 2027, Exhibiting A CAGR Of 5.3% During The Forecast Period (2019 To 2027). One of the defining characteristics of the Scottish Whisky Market is its adherence to traditional production methods. Scotch whisky is made from malted b
Read more

Monochloroacetic Acid (MCAA) Market Is Estimated To Witness High Growth Owing To Increasing Demand for Surfactants and Herbicides

Image
Monochloroacetic Acid (MCAA) Market The Monochloroacetic Acid (MCAA) Market is estimated to be valued at USD 676.52 Million in 2022 and is expected to exhibit a CAGR of 7.03% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Monochloroacetic Acid (MCAA) Market is driven by the increasing demand for surfactants and herbicides in several industries such as agriculture, pharmaceuticals, textiles, and personal care. MCAA is extensively used in the production of surfactants, herbicides, and carboxymethyl cellulose (CMC), which are essential in various applications. These applications include detergents, agrochemicals, pharmaceuticals, dyes, and cosmetics, among others. The versatile properties of MCAA, such as its ability to act as a raw material in the production of herbicides and surfactants, make it highly desirable in the market. Market Dynamics: The Monochloroacetic Acid (MCAA) Market is driven by two k
Read more